Magnetogenetics

Magnetogenetics and the Future of Remote Biological Control

David Alvaro, Ph.D.

Pharma's Almanac

Genomics

Integrated Spatial Genomics: Real Potential to Provide Truly Novel Biological Insights

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Molecular Machines

The Potential of Molecular Machines: Enhanced Drug Delivery and Beyond

Cynthia A. Challener, Ph.D.

Pharma's Almanac

3D Cell Culture

Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine

Elizabeth Abraham, Ph.D.; Catherine Siler, Ph.D.

Corning Life Sciences

Oncology

Addressing Cancer Therapy Resistance by Targeting Translational Regulation

Steve Worland, Ph.D.

eFFECTOR

Generative AI

Simplifying Target Discovery with an Artificial Intelligence Engine and Natural Language Chat

Petrina Kamya, Ph.D.

Insilico Medicine

Targeted Protein Degradation

Targeted Protein Degradation Provides Promising Alternative to Address Unmet Medical Needs

Henrik Daub, Ph.D.

NEOsphere Biotechnologies GmbH

Three Benefits of Using In Silico Technologies for Drug Discovery

Kimberly Brunner

Synthetic Biology

Synthetic Biology: A Potential Game-Changer for the Biopharma Industry

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.

Pharma's Almanac

Computational Drug Design

Integrating Experimental Data and Artificial Intelligence to Accelerate Drug Discovery

Ronald Dorenbos, Ph.D.; Guido Lanza

Charles River Laboratories

Big Data

Leveraging Big Data, Artificial Intelligence, and Machine Learning for Drug Discovery, Development, Manufacturing, and More

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.

Pharma's Almanac